Order Article Reprints

Guimarães CdJ, Carneiro TR, Frederico MJS, de Carvalho GGC, Little M, Freire VN, França VLB, do Amaral DN, Guedes JdS, Barreiro EJ, et al. Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. Pharmaceutics. 2023; 15(4):1282. https://doi.org/10.3390/pharmaceutics15041282

Guimarães, Celina de Jesus, Teiliane Rodrigues Carneiro, Marisa Jadna Silva Frederico, Guilherme G. C. de Carvalho, Matthew Little, Valder N. Freire, Victor L. B. França, Daniel Nascimento do Amaral, Jéssica de Siqueira Guedes, Eliezer J. Barreiro, and et al. 2023. "Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent" Pharmaceutics 15, no. 4: 1282. https://doi.org/10.3390/pharmaceutics15041282

Guimarães, C. d. J., Carneiro, T. R., Frederico, M. J. S., de Carvalho, G. G. C., Little, M., Freire, V. N., França, V. L. B., do Amaral, D. N., Guedes, J. d. S., Barreiro, E. J., Lima, L. M., Barros-Nepomuceno, F. W. A., & Pessoa, C. (2023). Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent. Pharmaceutics, 15(4), 1282. https://doi.org/10.3390/pharmaceutics15041282